ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,593 | -88.5% | 27,261 | -55.5% | 0.00% | – |
| Q2 2023 | $31,233 | -19.0% | 61,241 | 0.0% | 0.00% | – |
| Q1 2023 | $38,582 | -10.8% | 61,241 | -8.1% | 0.00% | – |
| Q4 2022 | $43,257 | -62.1% | 66,641 | +0.6% | 0.00% | – |
| Q3 2022 | $114,000 | +25.3% | 66,212 | -10.2% | 0.00% | – |
| Q2 2022 | $91,000 | +89.6% | 73,712 | -0.6% | 0.00% | – |
| Q1 2022 | $48,000 | -47.8% | 74,139 | -11.8% | 0.00% | – |
| Q4 2021 | $92,000 | -38.7% | 84,039 | +1.8% | 0.00% | – |
| Q3 2021 | $150,000 | -36.7% | 82,539 | -7.9% | 0.00% | – |
| Q2 2021 | $237,000 | -31.5% | 89,612 | -6.8% | 0.00% | – |
| Q1 2021 | $346,000 | +38.4% | 96,112 | -3.3% | 0.00% | – |
| Q4 2020 | $250,000 | -7.1% | 99,341 | -6.8% | 0.00% | – |
| Q3 2020 | $269,000 | -24.6% | 106,644 | -2.0% | 0.00% | – |
| Q2 2020 | $357,000 | +40.6% | 108,802 | +5.0% | 0.00% | – |
| Q1 2020 | $254,000 | -24.2% | 103,652 | +46.1% | 0.00% | – |
| Q4 2019 | $335,000 | +59.5% | 70,943 | +44.4% | 0.00% | – |
| Q3 2019 | $210,000 | -25.3% | 49,115 | +1.9% | 0.00% | – |
| Q2 2019 | $281,000 | +21.1% | 48,190 | -20.1% | 0.00% | – |
| Q1 2019 | $232,000 | +121.0% | 60,322 | +7.2% | 0.00% | – |
| Q4 2018 | $105,000 | -43.5% | 56,261 | -3.1% | 0.00% | – |
| Q3 2018 | $186,000 | +5.7% | 58,076 | -0.4% | 0.00% | – |
| Q2 2018 | $176,000 | +107.1% | 58,290 | +168.3% | 0.00% | – |
| Q1 2018 | $85,000 | -5.6% | 21,722 | 0.0% | 0.00% | – |
| Q4 2017 | $90,000 | -58.3% | 21,722 | -38.3% | 0.00% | – |
| Q3 2017 | $216,000 | -1.4% | 35,209 | -0.1% | 0.00% | – |
| Q2 2017 | $219,000 | -4.8% | 35,259 | -2.8% | 0.00% | -100.0% |
| Q1 2017 | $230,000 | +32.9% | 36,262 | +11.8% | 0.00% | – |
| Q4 2016 | $173,000 | -14.4% | 32,426 | -9.4% | 0.00% | -100.0% |
| Q3 2016 | $202,000 | -24.1% | 35,802 | -26.1% | 0.00% | 0.0% |
| Q2 2016 | $266,000 | -27.9% | 48,447 | -2.5% | 0.00% | 0.0% |
| Q1 2016 | $369,000 | -13.6% | 49,703 | -3.3% | 0.00% | -50.0% |
| Q4 2015 | $427,000 | +105.3% | 51,404 | +122.2% | 0.00% | +100.0% |
| Q3 2015 | $208,000 | -14.8% | 23,138 | +13.8% | 0.00% | 0.0% |
| Q2 2015 | $244,000 | -53.7% | 20,341 | -58.4% | 0.00% | -50.0% |
| Q1 2015 | $527,000 | – | 48,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Aquatic Capital Management LLC | 7,400 | $5,000 | 0.01% |